306 related articles for article (PubMed ID: 20614444)
1. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Strandberg T; Tonstad S; Gylling H
Cochrane Database Syst Rev; 2010 Jul; (7):CD006401. PubMed ID: 20614444
[TBL] [Abstract][Full Text] [Related]
2. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E
Cochrane Database Syst Rev; 2014 Jul; (7):CD006401. PubMed ID: 25054950
[TBL] [Abstract][Full Text] [Related]
3. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD006401. PubMed ID: 28685504
[TBL] [Abstract][Full Text] [Related]
4. Statins for children with familial hypercholesterolemia.
Vuorio A; Kuoppala J; Kovanen PT; Humphries SE; Tonstad S; Wiegman A; Drogari E; Ramaswami U
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31696945
[TBL] [Abstract][Full Text] [Related]
5. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with statins in children with familial hypercholesterolemia].
Kamińska E; Hennig M; Brandt A; Bautembach Minkowska J; Myśliwiec M
Dev Period Med; 2016; 20(4):328-334. PubMed ID: 28216488
[TBL] [Abstract][Full Text] [Related]
7. Severe xanthomatosis in heterozygous familial hypercholesterolemia.
Aljenedil S; Ruel I; Watters K; Genest J
J Clin Lipidol; 2018; 12(4):872-877. PubMed ID: 29778561
[TBL] [Abstract][Full Text] [Related]
8. 20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
Luirink IK; Wiegman A; Kusters DM; Hof MH; Groothoff JW; de Groot E; Kastelein JJP; Hutten BA
N Engl J Med; 2019 Oct; 381(16):1547-1556. PubMed ID: 31618540
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein apheresis: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
[TBL] [Abstract][Full Text] [Related]
10. Statin Treatments And Dosages In Children With Familial Hypercholesterolemia: Meta-Analysis.
Radaelli G; Sausen G; Cesa CC; Santos FS; Portal VL; Neyeloff JL; Pellanda LC
Arq Bras Cardiol; 2018 Dec; 111(6):810-821. PubMed ID: 30365601
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Statins in Children and Adolescents With Familial Hypercholesterolemia: A Systematic Review.
Dombalis S; Nash A
J Pediatr Health Care; 2021; 35(3):292-303. PubMed ID: 33342622
[TBL] [Abstract][Full Text] [Related]
12. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis.
Barkas F; Nomikos T; Liberopoulos E; Panagiotakos D
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823643
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
McCullough PA; Ballantyne CM; Sanganalmath SK; Langslet G; Baum SJ; Shah PK; Koren A; Mandel J; Davidson MH
Am J Cardiol; 2018 Apr; 121(8):940-948. PubMed ID: 29472008
[TBL] [Abstract][Full Text] [Related]
14. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
[TBL] [Abstract][Full Text] [Related]
16. When do paediatric patients with familial hypercholesterolemia need statin therapy?
Hennig M; Brandt A; Bautembach-Minkowska J; Świętoń D; Mickiewicz A; Chmara M; Wasąg B; Kamińska E; Balcerska A; Limon J; Rynkiewicz A; Gruchała M; Myśliwiec M
Dev Period Med; 2017; 21(1):43-50. PubMed ID: 28551692
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial.
Wiegman A; Hutten BA; de Groot E; Rodenburg J; Bakker HD; Büller HR; Sijbrands EJ; Kastelein JJ
JAMA; 2004 Jul; 292(3):331-7. PubMed ID: 15265847
[TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering agents for nephrotic syndrome.
Kong X; Yuan H; Fan J; Li Z; Wu T; Jiang L
Cochrane Database Syst Rev; 2013 Dec; (12):CD005425. PubMed ID: 24327265
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
